Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.100
-0.010 (-0.90%)
At close: Oct 15, 2026, 4:00 PM EDT
1.125
+0.025 (2.27%)
After-hours: Oct 15, 2026, 7:45 PM EDT
Veraxa Biotech AG Revenue
In the year 2025, Veraxa Biotech AG had annual revenue of 23.43K CHF. That makes Veraxa Biotech AG the 46,832nd largest company in the world by revenue and 7,043rd in the United States.
Revenue (ttm)
23.43K CHF
Revenue Growth
n/a
P/S Ratio
5,265.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
155.55M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.43K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
VRXA News
- 2 days ago - Veraxa Biotech presents in vivo, in vitro data for BiTAC-ADC technology platform - TheFly
- 2 days ago - VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress - GlobeNewsWire
- 8 days ago - Micro-Cap Stock Veraxa Biotech Is Down 96% This Year. Can Next-Gen Drug Testing Save It? - Barrons
- 8 days ago - Veraxa Biotech to implement FDA-aligned NAMs across development programs - TheFly
- 8 days ago - VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy - GlobeNewsWire
- 5 weeks ago - Veraxa Biotech appoints Raju Willener as CFO - TheFly
- 5 weeks ago - VERAXA Biotech Appoints Raju Willener as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Veraxa Biotech, Secarna announce initial results from AOC alliance - TheFly